Narasimha Kumar, Global Head of Technology and Data Services at BC Platforms, has authored a new article published in MedNous. In “How data from medical practice can inform care,” Kumar explores why traditional views of standard of care often lag behind how patients are actually treated — and how real‑world data is changing that. The article also examines how advances in analytics and AI are helping pharma teams turn complex clinical data into actionable insights, supporting better decisions on trial design and evidence generation across the drug lifecycle.
In “Building a reusable evidence foundation for confident decision-making,” published in The Evidence Base, Kumar explains how reusable data foundations are becoming essential for teams to generate trusted, decision-ready evidence across the product lifecycle.
In “AI in drug development is not a data problem – it’s an evidence problem,” published in MedCity News, Kumar explores how the challenge for organizations is no longer collecting data, but preserving the context, meaning, and relationships that transform data into usable evidence.
In “How data from medical practice can inform care,” published in MedNous, Kumar explores how real‑world data challenges traditional views of standard of care and enables more accurate, data‑driven decisions across trial design and evidence generation.
In “AI readiness in pharma – Getting the foundation right“, published in Bio‑IT World, Kumar examines how data fragmentation, complex regulations, and limited interoperability are slowing AI adoption—and what it takes to build trusted, cross‑border evidence ecosystems.